NCT04317365

Brief Summary

Corona virus is known as covid 19 And is transmitted through droplet infection

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2020

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 19, 2020

Completed
4 days until next milestone

First Posted

Study publicly available on registry

March 23, 2020

Completed
1 day until next milestone

Study Start

First participant enrolled

March 24, 2020

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 26, 2020

Completed
29 days until next milestone

Study Completion

Last participant's last visit for all outcomes

May 25, 2020

Completed
Last Updated

June 4, 2020

Status Verified

June 1, 2020

Enrollment Period

1 month

First QC Date

March 19, 2020

Last Update Submit

June 3, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • The number of pregnant women who know the exact symptoms of the disease

    The number of pregnant women who have awareness about the disease

    Within one month

Study Arms (2)

patients receiving remembering

ACTIVE COMPARATOR
Other: Women receiving extra remembering by healthcare

patients not receiving extra remembering

NO INTERVENTION

Interventions

Women receiving extra remembering by healthcare in covid infection

patients receiving remembering

Eligibility Criteria

Age18 Years - 43 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsPregnant women
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • pregnant women

You may not qualify if:

  • non pregnant women

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Algazeerah and Kasralainy hospital

Giza, Egypt

Location

MeSH Terms

Conditions

Respiratory Tract Infections

Condition Hierarchy (Ancestors)

InfectionsRespiratory Tract Diseases

Study Officials

  • Mahmoud Alalfy

    Algezeera hospital

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 19, 2020

First Posted

March 23, 2020

Study Start

March 24, 2020

Primary Completion

April 26, 2020

Study Completion

May 25, 2020

Last Updated

June 4, 2020

Record last verified: 2020-06

Locations